Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Instil Bio, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 95 | 1 | 79 | −15 |
| Shares | 119.2M | 5.00K | 101.7M | −17.5M (−14.7%) |
| Value | $577.0M | $24.0K | $64.1M | −$512.9M (−88.9%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Instil Bio, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 1,284,426 | $809.0K | 0.00% |
| Millennium Management LLC | 782,672 | $493.0K | 0.00% |
| Two Sigma Advisers, LP | 745,000 | $469.4K | 0.00% |
| Squarepoint Ops LLC | 562,728 | $354.5K | 0.00% |
| 683 Capital Management, LLC | 545,146 | $343.4K | 0.03% |
| Acadian Asset Management LLC | 456,567 | $287.0K | 0.00% |
| HRT Financial LP | 187,563 | $118.0K | 0.00% |
| Jane Street Group, LLC | 155,765 | $98.1K | 0.00% |
| Ergoteles LLC | 37,504 | $23.6K | 0.00% |
| Chicago Partners Investment Group LLC | 20,140 | $18.2K | 0.00% |
| Principal Financial Group Inc | 27,029 | $17.0K | 0.00% |
| Alpine Global Management, LLC | 22,954 | $14.0K | 0.00% |
| Point72 Middle East FZE | 18,278 | $11.5K | 0.00% |
| Occudo Quantitative Strategies LP | 17,427 | $11.0K | 0.00% |
| Gsa Capital Partners LLP | 16,449 | $10.0K | 0.00% |
| AQR Capital Management LLC | 12,507 | $7.88K | 0.00% |
| Avantax Planning Partners, Inc. | 10,000 | $6.30K | 0.00% |
| Aquatic Capital Management LLC | 8,700 | $5.00K | 0.00% |
| Bell Investment Advisors, Inc | 529 | $333 | 0.00% |
Sold out (34)
Institutions that held Instil Bio, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
Not filed for Q4 2022 yet (1)
Institutions that held Instil Bio, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| ACT Capital Management, LLC | 5,000 | $24.0K |